Clinical Trial Update: Fecal Calprotectin for Prediction of Esophageal Varices in Cirrhotic Patients

View source ↗

Summary

This clinical trial update indicates a study evaluating fecal calprotectin as a predictor of esophageal varices in cirrhotic patients, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cirrhosis
• Esophageal Varices

Snippet

Sponsor: Tanta University | Conditions: Esophageal Varices | Status: RECRUITING